Since the liver produces about 90% of AAT in our body, intrahepatic Z-AAT retention can cause liver damage with variable clinical presentations ranging from neonatal cholestasis to liver cirrhosis and hepatocellular carcinoma in adults [8]. Here, SERPINA1 is linked to hepatocellular carcinoma.